FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890470834> ?p ?o ?g. }

• W2890470834 abstract "Objectives: Acute coronary syndrome (ACS) is the major cause of mortality worldwide and caused mainly by atherosclerosis of coronary arteries. Apolipoprotein B100 (ApoB100) is a major component of low-density lipoprotein (LDL) and its oxidation can trigger inflammation in vascular endothelial cells leading to atherosclerosis. The association between antibodies to ApoB100-derived antigens and atherosclerotic diseases has been studied in recent years, but the findings appear to be controversial. The present study developed an ELISA in-house with ApoB100-derived peptide antigens to circulating anti-ApoB100 IgG antibodies in patients with ACS. Methods: Fifteen ApoB100-derived peptide antigens (Ag1–Ag15) were designed to develop an in-house ELISA for the detection of circulating anti-ApoB100 IgG levels in 350 patients with ACS and 201 control subjects amongst a Chinese population. Binary logistic regression was applied to examine the differences in anti-ApoB IgG levels between the patient group and the control group with adjustment for a number of confounding factors; the correlation between anti-ApoB100 IgG levels and clinical characteristics was also tested. Results: Patients with ACS had significantly higher levels of plasma IgG for Ag1 (adjusted P&lt;0.001) and Ag10 antigens (adjusted P&lt;0.001). There was no significant increase in the levels of IgG to the other 13 antigens in these ACS patients. In the control group, anti-Ag10 IgG levels were positively correlated with age, high-density lipoprotein (HDL), and ApoA levels (P≤0.001 for all) and negatively correlated with blood triglyceride (TG) (P=0.008); in the patient group, anti-Ag10 IgG levels were positively correlated with LDL (P=0.003), and negatively correlated with ApoA (P=0.048) and systolic blood pressure (SBP) (P=0.036). The area under ROC (receiver operator characteristic) curve (AUC) was 0.612 (95% confidence interval (CI): 0.560–0.664; P&lt;0.001) in anti-Ag1 IgG assay and 0.621 (95% CI: 0.569–0.672; P&lt;0.001) in anti-Ag10 IgG assay. Conclusion: Circulating IgG for ApoB100-derived peptide antigens may be a useful biomarker of ACS, although anti-ApoB IgG levels were not associated with the coronary artery plaque burden characterized by the coronary Gensini score." @default.
• W2890470834 created "2018-09-27" @default.
• W2890470834 creator A5002396093 @default.
• W2890470834 creator A5014388103 @default.
• W2890470834 creator A5052655646 @default.
• W2890470834 creator A5068769347 @default.
• W2890470834 creator A5072210428 @default.
• W2890470834 creator A5079586613 @default.
• W2890470834 creator A5088602486 @default.
• W2890470834 creator A5088891531 @default.
• W2890470834 date "2018-11-07" @default.
• W2890470834 modified "2023-09-23" @default.
• W2890470834 title "Associations between circulating IgG antibodies to Apolipoprotein B100-derived peptide antigens and acute coronary syndrome in a Chinese Han population" @default.
• W2890470834 cites W1490762350 @default.
• W2890470834 cites W172039651 @default.
• W2890470834 cites W1772844052 @default.
• W2890470834 cites W1940612640 @default.
• W2890470834 cites W1966699435 @default.
• W2890470834 cites W1967040563 @default.
• W2890470834 cites W1967946273 @default.
• W2890470834 cites W1977516038 @default.
• W2890470834 cites W1978373894 @default.
• W2890470834 cites W1980512218 @default.
• W2890470834 cites W1981784337 @default.
• W2890470834 cites W1982648863 @default.
• W2890470834 cites W1994562390 @default.
• W2890470834 cites W1996373371 @default.
• W2890470834 cites W1999047083 @default.
• W2890470834 cites W2000348588 @default.
• W2890470834 cites W2008960002 @default.
• W2890470834 cites W2013519087 @default.
• W2890470834 cites W2016755061 @default.
• W2890470834 cites W2050957960 @default.
• W2890470834 cites W2051653575 @default.
• W2890470834 cites W2052610626 @default.
• W2890470834 cites W2060034277 @default.
• W2890470834 cites W2088084815 @default.
• W2890470834 cites W2098224362 @default.
• W2890470834 cites W2100137584 @default.
• W2890470834 cites W2104394285 @default.
• W2890470834 cites W2109855001 @default.
• W2890470834 cites W2121734411 @default.
• W2890470834 cites W2122769971 @default.
• W2890470834 cites W2122779464 @default.
• W2890470834 cites W2126130360 @default.
• W2890470834 cites W2134173538 @default.
• W2890470834 cites W2139483173 @default.
• W2890470834 cites W2140998385 @default.
• W2890470834 cites W2149011208 @default.
• W2890470834 cites W2157291214 @default.
• W2890470834 cites W2161958345 @default.
• W2890470834 cites W2164765228 @default.
• W2890470834 cites W2168175864 @default.
• W2890470834 cites W2169567787 @default.
• W2890470834 cites W2224019305 @default.
• W2890470834 cites W2288793506 @default.
• W2890470834 cites W2312246162 @default.
• W2890470834 cites W2415102887 @default.
• W2890470834 cites W2805078756 @default.
• W2890470834 cites W350446038 @default.
• W2890470834 cites W4205653014 @default.
• W2890470834 cites W4211104669 @default.
• W2890470834 cites W55869762 @default.
• W2890470834 cites W57335222 @default.
• W2890470834 cites W84721599 @default.
• W2890470834 doi "https://doi.org/10.1042/bsr20180450" @default.
• W2890470834 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6239261" @default.
• W2890470834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30242056" @default.
• W2890470834 hasPublicationYear "2018" @default.
• W2890470834 type Work @default.
• W2890470834 sameAs 2890470834 @default.
• W2890470834 citedByCount "2" @default.
• W2890470834 countsByYear W28904708342019 @default.
• W2890470834 countsByYear W28904708342021 @default.
• W2890470834 crossrefType "journal-article" @default.
• W2890470834 hasAuthorship W2890470834A5002396093 @default.
• W2890470834 hasAuthorship W2890470834A5014388103 @default.
• W2890470834 hasAuthorship W2890470834A5052655646 @default.
• W2890470834 hasAuthorship W2890470834A5068769347 @default.
• W2890470834 hasAuthorship W2890470834A5072210428 @default.
• W2890470834 hasAuthorship W2890470834A5079586613 @default.
• W2890470834 hasAuthorship W2890470834A5088602486 @default.
• W2890470834 hasAuthorship W2890470834A5088891531 @default.
• W2890470834 hasBestOaLocation W28904708341 @default.
• W2890470834 hasConcept C126322002 @default.
• W2890470834 hasConcept C134018914 @default.
• W2890470834 hasConcept C147483822 @default.
• W2890470834 hasConcept C159654299 @default.
• W2890470834 hasConcept C164585084 @default.
• W2890470834 hasConcept C203014093 @default.
• W2890470834 hasConcept C2776104379 @default.
• W2890470834 hasConcept C2777698277 @default.
• W2890470834 hasConcept C2778163477 @default.
• W2890470834 hasConcept C2780072125 @default.
• W2890470834 hasConcept C2780745583 @default.
• W2890470834 hasConcept C2908647359 @default.
• W2890470834 hasConcept C500558357 @default.
• W2890470834 hasConcept C62746215 @default.
• W2890470834 hasConcept C71924100 @default.
• W2890470834 hasConcept C99454951 @default.

• next